Clinical Trial Update: A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of crofelemer for diarrhea-predominant irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Crofelemer (crofelemer)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Irritable Bowel Syndrome, Colonic Diseases | Phase 2 | Status: COMPLETED